
|Articles|December 9, 2022
A new era for E. coli: Revolutionizing microbial bioproduction with chemically defined fermentation media
Author(s)Thermo Fisher Scientific
Despite the long-standing popularity of E. coli for microbial bioprocessing, the options for growth media have been traditionally limited. This media has often included animal origin (AO) components which can reduce batch-to-batch consistency and present safety risks to patients. Significant effort from across the industry has been focused on developing the first commercially available chemically defined microbial media. Read the article and learn how the Gibco™ Bacto™ CD Supreme Fermentation Production Media is helping to manufacture the next generation of biopharmaceuticals.
Trending on Pharmaceutical Technology
1
Using Automation to Enhance Pharmaceutical Manufacturing
2
FDA Activity Round Up – July 2026
3
Engineering High-Speed Pen Injector Final Assembly Machine: Solving the Cartridge Press-Fit Challenge
4
Hidden Cost Drivers in Oligonucleotide Manufacturing
5